CH
Insider
Craig C. Hopkinson
EVP R&D, Chief Medical OfficerCraig C. Hopkinson (EVP R&D, Chief Medical Officer) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Alkermes plc (ALKS). The largest single filing was $437K of ALKS (9,000 sh × $48.58, as filed), executed Aug 3.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
14
0 buys · 14 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.9M
shares × price, as filed
Last traded
Sep 1
Filed Sep 1
Median ADV $102.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $23.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
14 filings
Sector per market data · by filing · past 12 months
Most traded names
ALKSRecent filings
ALKSSALE
Alkermes plc
View filing →
$2.0M61,151 sh × $32.07
Exec Dec 9 2024
Filed Dec 9 2024 · 5:30 PM ET ALKSSALE Alkermes plc View filing → $290K
9,221 sh × $31.50
Exec Dec 5 2024
Filed Dec 5 2024 · 5:30 PM ET ALKSSALE Alkermes plc View filing → $442K
14,349 sh × $30.77
Exec Dec 4 2024
Filed Dec 4 2024 · 5:30 PM ET ALKSSALE Alkermes plc View filing → $1.8M
58,996 sh × $30.08
Exec Nov 11 2024
Filed Nov 12 2024 · 5:30 PM ET ALKSSALE Alkermes plc View filing → $309K
10,471 sh × $29.53
Exec Nov 6 2024
Filed Nov 6 2024 · 5:30 PM ET